Centene Net Income/Loss 2012-2026 | CNC

Centene annual/quarterly net income/loss history and growth rate from 2012 to 2026. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
  • Centene net income/loss for the quarter ending March 31, 2026 was $-5.577B, a 285.04% decline year-over-year.
  • Centene net income/loss for the twelve months ending March 31, 2026 was $86M, a 99.06% decline year-over-year.
  • Centene annual net income/loss for 2024 was $3.294B, a 22.05% increase from 2023.
  • Centene annual net income/loss for 2023 was $2.699B, a 124.54% increase from 2022.
  • Centene annual net income/loss for 2022 was $1.202B, a 10.03% decline from 2021.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Centene Annual Net Income/Loss
(Millions of US $)
2024 $3,294
2023 $2,699
2022 $1,202
2021 $1,336
2020 $1,794
2019 $1,309
2018 $894
2017 $808
2016 $561
2015 $357
2014 $264
2013 $166
2012 $-11
2011 $108
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $18.343B $194.777B
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $276.233B 18.66
Cigna Group (CI) United States $71.482B 9.09
Humana (HUM) United States $23.068B 11.22
Molina Healthcare (MOH) United States $7.599B 13.70
Select Medical Holdings (SEM) United States $2.030B 14.23
Joint (JYNT) United States $0.125B 0.00
Aethlon Medical (AEMD) United States $0.003B 0.00